500087 and EQCIPLA Related Headlines

Go Back

Feb 27, 2026 11:28AM Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy

500087 and EQCIPLA Related Press Releases

Go Back

Feb 27, 2026 11:28AM Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy

500087 and EQCIPLA Related SEC Filings

Go Back